NAFLD and CVD both share several common metabolic risk factors such as genetics, systemic inflammation, endothelial dysfunction, hepatic insulin resistance, adipose tissue dysfunction, oxidative stress, and lipid metabolism [26, 27]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.